Merit Medical Systems Toekomstige groei
Future criteriumcontroles 2/6
Merit Medical Systems zal naar verwachting groeien in winst en omzet met respectievelijk 14.2% en 7% per jaar. De winst per aandeel zal naar verwachting groeien met 13.7% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 29% zijn.
Belangrijke informatie
14.2%
Groei van de winst
13.7%
Groei van de winst per aandeel
| Medical Equipment winstgroei | 17.1% |
| Inkomstengroei | 7.0% |
| Toekomstig rendement op eigen vermogen | 29.0% |
| Dekking van analisten | Good |
| Laatst bijgewerkt | 31 Oct 2024 |
Recente toekomstige groei-updates
Merit Medical Systems, Inc. (NASDAQ:MMSI) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
Nov 02
Results: Merit Medical Systems, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
May 03Recent updates
Merit Medical Systems, Inc. (NASDAQ:MMSI) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
Nov 02Is Merit Medical Systems (NASDAQ:MMSI) A Risky Investment?
Nov 01Merit Medical Systems - Impressive Momentum
Sep 17The Price Is Right For Merit Medical Systems, Inc. (NASDAQ:MMSI)
Sep 17Why Merit Medical Systems, Inc. (NASDAQ:MMSI) Could Be Worth Watching
Sep 04Merit Medical Systems (NASDAQ:MMSI) Is Doing The Right Things To Multiply Its Share Price
Aug 22These 4 Measures Indicate That Merit Medical Systems (NASDAQ:MMSI) Is Using Debt Safely
Jul 31Merit Medical Systems: Steady Wins The Day
Jul 05Merit Medical Systems (NASDAQ:MMSI) Ticks All The Boxes When It Comes To Earnings Growth
Jun 19Merit Medical: Undervalued With Multiple Growth Drivers In Play
Jun 15Merit Medical Systems (NASDAQ:MMSI) Is Doing The Right Things To Multiply Its Share Price
May 23It Looks Like Shareholders Would Probably Approve Merit Medical Systems, Inc.'s (NASDAQ:MMSI) CEO Compensation Package
May 09Results: Merit Medical Systems, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
May 03Is Merit Medical Systems (NASDAQ:MMSI) Using Too Much Debt?
Apr 30Merit Medical Systems, Inc. (NASDAQ:MMSI) Not Lagging Market On Growth Or Pricing
Apr 16When Should You Buy Merit Medical Systems, Inc. (NASDAQ:MMSI)?
Apr 02Merit Medical Systems: Solid Performer, Fully Valued
Mar 03Analyst Estimates: Here's What Brokers Think Of Merit Medical Systems, Inc. (NASDAQ:MMSI) After Its Full-Year Report
Mar 02We Ran A Stock Scan For Earnings Growth And Merit Medical Systems (NASDAQ:MMSI) Passed With Ease
Feb 05The Returns At Merit Medical Systems (NASDAQ:MMSI) Aren't Growing
Jan 23What You Can Learn From Merit Medical Systems, Inc.'s (NASDAQ:MMSI) P/E
Dec 18These 4 Measures Indicate That Merit Medical Systems (NASDAQ:MMSI) Is Using Debt Safely
Nov 21What Is Merit Medical Systems, Inc.'s (NASDAQ:MMSI) Share Price Doing?
Nov 06Estimating The Fair Value Of Merit Medical Systems, Inc. (NASDAQ:MMSI)
Oct 23Does Merit Medical Systems (NASDAQ:MMSI) Deserve A Spot On Your Watchlist?
Sep 11Return Trends At Merit Medical Systems (NASDAQ:MMSI) Aren't Appealing
Aug 13Is Now An Opportune Moment To Examine Merit Medical Systems, Inc. (NASDAQ:MMSI)?
Jul 31Is Merit Medical Systems (NASDAQ:MMSI) A Risky Investment?
Jul 17Is Now The Time To Put Merit Medical Systems (NASDAQ:MMSI) On Your Watchlist?
Jun 07Is It Time To Consider Buying Merit Medical Systems, Inc. (NASDAQ:MMSI)?
May 01We Think Merit Medical Systems (NASDAQ:MMSI) Can Manage Its Debt With Ease
Apr 16Returns On Capital At Merit Medical Systems (NASDAQ:MMSI) Have Hit The Brakes
Apr 02Is Now The Time To Put Merit Medical Systems (NASDAQ:MMSI) On Your Watchlist?
Mar 01Merit Medical Systems, Inc.'s (NASDAQ:MMSI) Intrinsic Value Is Potentially 24% Below Its Share Price
Feb 01Is Now The Time To Look At Buying Merit Medical Systems, Inc. (NASDAQ:MMSI)?
Jan 12Merit Medical Systems (NASDAQ:MMSI) Seems To Use Debt Rather Sparingly
Dec 29Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2026 | 1,549 | 177 | 191 | 257 | 8 |
| 12/31/2025 | 1,470 | 147 | 175 | 210 | 11 |
| 12/31/2024 | 1,348 | 123 | 146 | 191 | 11 |
| 9/30/2024 | 1,326 | 120 | 173 | 214 | N/A |
| 6/30/2024 | 1,301 | 117 | 177 | 218 | N/A |
| 3/31/2024 | 1,283 | 102 | 131 | 167 | N/A |
| 12/31/2023 | 1,257 | 94 | 108 | 145 | N/A |
| 9/30/2023 | 1,226 | 100 | 68 | 111 | N/A |
| 6/30/2023 | 1,198 | 90 | 45 | 95 | N/A |
| 3/31/2023 | 1,173 | 85 | 65 | 117 | N/A |
| 12/31/2022 | 1,151 | 75 | 66 | 114 | N/A |
| 9/30/2022 | 1,136 | 62 | 89 | 132 | N/A |
| 6/30/2022 | 1,116 | 58 | 87 | 122 | N/A |
| 3/31/2022 | 1,101 | 48 | 90 | 124 | N/A |
| 12/31/2021 | 1,075 | 48 | 116 | 147 | N/A |
| 9/30/2021 | 1,054 | 43 | 105 | 138 | N/A |
| 6/30/2021 | 1,031 | 28 | 133 | 168 | N/A |
| 3/31/2021 | 969 | 4 | 131 | 172 | N/A |
| 12/31/2020 | 964 | -10 | 116 | 165 | N/A |
| 9/30/2020 | 964 | -29 | 96 | 155 | N/A |
| 6/30/2020 | 963 | -30 | 44 | 115 | N/A |
| 3/31/2020 | 1,000 | -4 | 16 | 93 | N/A |
| 12/31/2019 | 995 | 5 | -4 | 78 | N/A |
| 9/30/2019 | 970 | 19 | -3 | 75 | N/A |
| 6/30/2019 | 949 | 39 | 17 | 87 | N/A |
| 3/31/2019 | 918 | 43 | 24 | 92 | N/A |
| 12/31/2018 | 883 | 42 | 20 | 87 | N/A |
| 9/30/2018 | 840 | 40 | 23 | 82 | N/A |
| 6/30/2018 | 798 | 19 | N/A | 63 | N/A |
| 3/31/2018 | 760 | 18 | N/A | 55 | N/A |
| 12/31/2017 | 728 | 28 | N/A | 63 | N/A |
| 9/30/2017 | 695 | 28 | N/A | 61 | N/A |
| 6/30/2017 | 672 | 33 | N/A | 63 | N/A |
| 3/31/2017 | 637 | 31 | N/A | 57 | N/A |
| 12/31/2016 | 604 | 20 | N/A | 54 | N/A |
| 9/30/2016 | 580 | 19 | N/A | 49 | N/A |
| 6/30/2016 | 559 | 23 | N/A | 55 | N/A |
| 3/31/2016 | 546 | 23 | N/A | 62 | N/A |
| 12/31/2015 | 542 | 24 | N/A | 69 | N/A |
| 9/30/2015 | 537 | 26 | N/A | 79 | N/A |
| 6/30/2015 | 529 | 29 | N/A | 74 | N/A |
| 3/31/2015 | 520 | 25 | N/A | 65 | N/A |
| 12/31/2014 | 510 | 23 | N/A | 53 | N/A |
| 9/30/2014 | 497 | 21 | N/A | 49 | N/A |
| 6/30/2014 | 483 | 19 | N/A | 57 | N/A |
| 3/31/2014 | 464 | 19 | N/A | 56 | N/A |
| 12/31/2013 | 449 | 17 | N/A | 51 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei MMSI ( 14.2% per jaar) ligt boven de spaarquote ( 2.6% ).
Winst versus markt: De winst van MMSI ( 14.2% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 15.4% per jaar).
Hoge groeiwinsten: De winst van MMSI zal naar verwachting groeien, maar niet aanzienlijk.
Omzet versus markt: De omzet van MMSI ( 7% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 8.9% per jaar).
Hoge groei-inkomsten: De omzet van MMSI ( 7% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen MMSI zal naar verwachting over 3 jaar hoog zijn ( 29 %)